| Emergence of West Nile virus lineage 2 in Europe: a review on the introduction and spread of a mosquito-borne disease LM Hernández-Triana, CL Jeffries, KL Mansfield, G Carnell, AR Fooks, ... Frontiers in public health 2, 271, 2014 | 162 | 2014 |
| Stalking influenza by vaccination with pre-fusion headless HA mini-stem SA Valkenburg, VVA Mallajosyula, OTW Li, AWH Chin, G Carnell, ... Scientific reports 6 (1), 22666, 2016 | 137 | 2016 |
| Pseudotype-based neutralization assays for influenza: a systematic analysis GW Carnell, F Ferrara, K Grehan, CP Thompson, NJ Temperton Frontiers in immunology 6, 140476, 2015 | 95 | 2015 |
| SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress KM Scherer, L Mascheroni, GW Carnell, LCS Wunderlich, S Makarchuk, ... Science advances 8 (1), eabl4895, 2022 | 67 | 2022 |
| Development of a clinical MALDI-ToF mass spectrometry assay for SARS-CoV-2: Rational design and multi-disciplinary team work RK Iles, R Zmuidinaite, JK Iles, G Carnell, A Sampson, JL Heeney Diagnostics 10 (10), 746, 2020 | 56 | 2020 |
| Production, titration, neutralisation, storage and lyophilisation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lentiviral pseudotypes C Di Genova, A Sampson, S Scott, D Cantoni, M Mayora-Neto, E Bentley, ... Bio-protocol 11 (21), e4236-e4236, 2021 | 54* | 2021 |
| Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor ES Giotis, G Carnell, EF Young, S Ghanny, P Soteropoulos, LF Wang, ... Nature microbiology 4 (12), 2035-2038, 2019 | 47 | 2019 |
| SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses GW Carnell, KA Ciazynska, DA Wells, X Xiong, ET Aguinam, ... Journal of virology 95 (15), 10.1128/jvi. 00203-21, 2021 | 39 | 2021 |
| A naturally protective epitope of limited variability as an influenza vaccine target CP Thompson, J Lourenço, AA Walters, U Obolski, M Edmans, DS Palmer, ... Nature communications 9 (1), 3859, 2018 | 38 | 2018 |
| Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens DM Favara, ML Ceron-Gutierrez, GW Carnell, JL Heeney, P Corrie, ... Emerging Microbes & Infections 9 (1), 2728-2731, 2020 | 35 | 2020 |
| Cross-protective immune responses induced by sequential influenza virus infection and by sequential vaccination with inactivated influenza vaccines W Dong, Y Bhide, F Sicca, T Meijerhof, K Guilfoyle, OG Engelhardt, ... Frontiers in immunology 9, 2312, 2018 | 35 | 2018 |
| Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses AL McNaughton, RS Paton, M Edmans, J Youngs, J Wellens, P Phalora, ... JCI insight 7 (13), 2022 | 31 | 2022 |
| Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases J Castillo-Olivares, DA Wells, M Ferrari, ACY Chan, P Smith, ... Frontiers in Immunology, 4711, 2021 | 27 | 2021 |
| An optimized method for the production using PEI, titration and neutralization of SARS-CoV spike luciferase pseudotypes G Carnell, K Grehan, F Ferrara, E Molesti, N Temperton Bio-protocol 7 (16), e2514-e2514, 2017 | 27 | 2017 |
| Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK A Nadesalingam, D Cantoni, DA Wells, ET Aguinam, M Ferrari, P Smith, ... The Lancet Microbe 2 (9), e416-e418, 2021 | 24 | 2021 |
| Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release H Stewart, R Palmulli, KH Johansen, N McGovern, OM Shehata, ... EMBO reports 24 (12), e57224, 2023 | 21* | 2023 |
| Cross-reactive and lineage-specific single domain antibodies against influenza B hemagglutinin W Ramage, T Gaiotto, C Ball, P Risley, GW Carnell, N Temperton, ... Antibodies 8 (1), 14, 2019 | 18 | 2019 |
| Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease J Castillo-Olivares, DA Wells, M Ferrari, A Chan, P Smith, ... medRxiv, 2021.05. 21.21257572, 2021 | 17 | 2021 |
| Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses AT Sampson, J Heeney, D Cantoni, M Ferrari, MS Sans, C George, ... Viruses 13 (8), 1579, 2021 | 16 | 2021 |
| Nanobodies mapped to cross-reactive and divergent epitopes on A (H7N9) influenza hemagglutinin using yeast display T Gaiotto, W Ramage, C Ball, P Risley, GW Carnell, N Temperton, ... Scientific Reports 11 (1), 3126, 2021 | 15 | 2021 |
Nigel TempertonProfessor of Molecular VirologyVerified email at kent.ac.uk
